Peripheral plasma membrane protein CASK is a protein that in humans is encoded by the CASKgene.[5][6] This gene is also known by several other names: CMG 2 (CAMGUK protein 2), calcium/calmodulin-dependent serine protein kinase 3 and membrane-associated guanylate kinase 2. CASK gene mutations are the cause of XL-ID with or without nystagmus and MICPCH, an X-linked neurological disorder.
This gene is located on the short arm of the X chromosome (Xp11.4). It is 404,253 bases in length and lies on the Crick (minus) strand. The encoded protein has 926 amino acids with a predicted molecular weight of 105,123 daltons.
This protein is a multidomain scaffolding protein with a role in synaptic transmembrane protein anchoring and ion channel trafficking. It interacts with the transcription factor TBR1 and binds to several cell-surface proteins including neurexins and syndecans.
This gene has been implicated in X-linked mental retardation,[7] including specifically mental retardation and microcephaly with pontine and cerebellar hypoplasia.[8] The role of CASK in disease is primarily associated with a loss of function (under expression) of the CASK gene as a result of a deletion, missense or splice mutation.[9] It appears that mutations in the gene lead to diminished amounts of the protein being coded. As a result, CASK is unable to form complexes with other proteins leading to a cascade of events. Research has shown there is significant down-regulation of the genes involved in pre-synaptic development and of CASK protein interactors.[10]
Males affected by CASK variants tend to have more severe symptoms than females due to the X-linked nature of the disease. These genetic issues are often fatal in the womb for male embryos[11][12] or else lead to infant mortality. Females with CASK mutations have variable phenotypes with moderate to severe intellectual disability. CASK missense mutations and some splice mutations can lead to the milder neurodevelopmental phenotype.[12]
CASK related disorders are mainly found in girls. The prevalence is unknown but generally thought to be below 400 cases worldwide. Patients are often born healthy but within the first few months of life show progressive microcephaly. Although there can be prenatal deceleration of head circumference growth, the majority of cases will not be diagnosed according to current recommendations for fetal CNS routine assessment.[13]
The exact mode of pathology is not clear, but evidence from mice models indicates CASK deficiency in neurones causes the following effects:[14]
reduced levels of associated proteins such as Mint1[15] and neurexin
Higher levels of Neuroligin 1
Increased glutamate release at synapses and reduced GABA release affecting the E/I balance in maturing neural circuits[16]
Down-regulation of GluN2B resulting in disruption of synaptic E/I balance[17]
Even slight changes in CASK expression in humans leads to dysregulation of the formation of presynapses, especially in inhibitory neurones.[10]
^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Dimitratos SD, Stathakis DG, Nelson CA, Woods DF, Bryant PJ (July 1998). "The location of human CASK at Xp11.4 identifies this gene as a candidate for X-linked optic atrophy". Genomics. 51 (2): 308–309. doi:10.1006/geno.1998.5404. PMID9722958.
^Najm J, Horn D, Wimplinger I, Golden JA, Chizhikov VV, Sudi J, et al. (September 2008). "Mutations of CASK cause an X-linked brain malformation phenotype with microcephaly and hypoplasia of the brainstem and cerebellum". Nature Genetics. 40 (9): 1065–1067. doi:10.1038/ng.194. PMID19165920. S2CID91094953.
^Gafner M, Boltshauser E, D'Abrusco F, Battini R, Romaniello R, D'Arrigo S, et al. (September 2022). "Expanding the natural history of CASK-related disorders to the prenatal period". Developmental Medicine and Child Neurology. 65 (4): 544–550. doi:10.1111/dmcn.15419. hdl:11568/1157845. PMID36175354. S2CID252622483.
^Saitsu H, Kato M, Mizuguchi T, Hamada K, Osaka H, Tohyama J, et al. (June 2008). "De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy". Nature Genetics. 40 (6): 782–788. doi:10.1038/ng.150. PMID18469812. S2CID1113528.
^Qi J, Su Y, Sun R, Zhang F, Luo X, Yang Z, Luo X (March 2005). "CASK inhibits ECV304 cell growth and interacts with Id1". Biochemical and Biophysical Research Communications. 328 (2): 517–521. doi:10.1016/j.bbrc.2005.01.014. PMID15694377.
^ abZhang Y, Luan Z, Liu A, Hu G (May 2001). "The scaffolding protein CASK mediates the interaction between rabphilin3a and beta-neurexins". FEBS Letters. 497 (2–3): 99–102. doi:10.1016/S0014-5793(01)02450-4. PMID11377421. S2CID33119468.
Zhu ZQ, Wang D, Xiang D, Yuan YX, Wang Y (January 2014). "Calcium/calmodulin-dependent serine protein kinase is involved in exendin-4-induced insulin secretion in INS-1 cells". Metabolism. 63 (1): 120–126. doi:10.1016/j.metabol.2013.09.009. PMID24140090.
Wang Y, Li R, Du D, Zhang C, Yuan H, Zeng R, Chen Z (April 2006). "Proteomic analysis reveals novel molecules involved in insulin signaling pathway". Journal of Proteome Research. 5 (4): 846–855. CiteSeerX10.1.1.583.5128. doi:10.1021/pr050391m. PMID16602692.
Daniels DL, Cohen AR, Anderson JM, Brünger AT (April 1998). "Crystal structure of the hCASK PDZ domain reveals the structural basis of class II PDZ domain target recognition". Nature Structural Biology. 5 (4): 317–325. doi:10.1038/nsb0498-317. PMID9546224. S2CID20608889.
Stevenson D, Laverty HG, Wenwieser S, Douglas M, Wilson JB (October 2000). "Mapping and expression analysis of the human CASK gene". Mammalian Genome. 11 (10): 934–937. doi:10.1007/s003350010170. PMID11003712. S2CID35231493.
Zhang Y, Luan Z, Liu A, Hu G (May 2001). "The scaffolding protein CASK mediates the interaction between rabphilin3a and beta-neurexins". FEBS Letters. 497 (2–3): 99–102. doi:10.1016/S0014-5793(01)02450-4. PMID11377421. S2CID33119468.
Olsen O, Liu H, Wade JB, Merot J, Welling PA (January 2002). "Basolateral membrane expression of the Kir 2.3 channel is coordinated by PDZ interaction with Lin-7/CASK complex". American Journal of Physiology. Cell Physiology. 282 (1): C183–C195. doi:10.1152/ajpcell.00249.2001. PMID11742811.